首页> 外文期刊>The Internet Journal of Pathology >Low-grade Collecting Duct Carcinoma Of The Kidney: A Potential Mimic Of Conventional Clear Cell Carcinoma
【24h】

Low-grade Collecting Duct Carcinoma Of The Kidney: A Potential Mimic Of Conventional Clear Cell Carcinoma

机译:肾脏低度收集管癌:常规透明细胞癌的潜在模仿物

获取原文
           

摘要

Collecting duct carcinoma of the kidney is a well-known, but relatively uncommon tumor characterized by a high cytologic grade, desmoplastic stroma and a poor clinical outcome. Since 1979, however, there have been several reports of low-grade renal carcinoma of putative collecting duct origin. These low-grade tumors were extensively papillary, tubulopapillary or tubulocystic, with a low nuclear grade (usually Furhman grade 1 or 2). Most have conferred a benign follow-up course, even when treated only by partial nephrectomy. The previous reports of such tumors have been variably characterized immunohistochemically and ultrastructurally. We report the cases of a low-grade renal carcinoma of collecting duct origin, arising in the right renal lower pole of a 47-year-old-male with a history of gout and nephrolithiasis. Microscopically, the tumor showed a tubular and tubulocystic pattern and was composed almost exclusively of clear cells, closely mimicking conventional (clear cell) renal cell carcinoma. Tumor cells stained positively for PAS, showed droplet-like staining with Hale's colloidal iron, were variably alcian blue positive and were mucicarmine negative. They were reactive with immunohistochemical antibodies to peanut agglutinin (PNA), Ulex europaeus-1 agglutinin (UEA-1), pan-cytokeratin, CAM 5.2, cytokeratin 7, epithelial membrane antigen (EMA) and vimentin. Electron microscopy showed microvillous-lined tubules, desmosomes, and tonofilaments, with a paucity of mitochondria. The patient was treated by partial nephrectomy and has been without evidence of disease for a follow-up period of 10 months. Introduction Collecting duct carcinomas of the kidney are relatively uncommon neoplasms, generally regarded as high grade tumors expressing phenotypic markers of the normal renal collecting duct, which include high molecular weight cytokeratin (HMWK, 34+E12), Ulex europaeus-1 agglutinin (UEA-1), peanut agglutinin (PNA) and epithelial membrane antigen (EMA) 1,2,3,4. These tumors are grossly situated in the renal medulla with a firm consistency and gray-white color. Microscopically, they are usually tubular or tubulopapillary with a high nuclear grade and markedly desmoplastic stroma. Clinical outcome is poor, with approximately 66% of patients dying of disease within 2 years of diagnosis 4.In 1979, Cromie et al described a low-grade renal carcinoma characterized by a tubular and papillary microscopic pattern, low nuclear grade, absence of desmoplasia and apparent origin from collecting duct epithelium. Follow up clinical course was benign following radical nephrectomy 5. Since that time, additional reports of low-grade renal carcinomas, apparently of collecting duct or distal nephron origin, have been reported, almost all having a benign follow-up clinical course following either radical or partial nephrectomy 6,7,8,9,10. Most of these have been studied histochemically and immunohistochemically, with only 10 examined ultrastructurally 5,7,8. The importance of the presently described case lies in its striking histologic similarity to conventional (clear cell) renal cell carcinoma, with which it might have easily been confused. Case Report A 47-year-old white male was found to have a 2.0-cm solid mass at the lower pole of his right kidney during evaluation for microscopic hematuria. His past medical history was significant for Crohn's disease, type II Diabetes Mellitus and gout. He suffered a single episode of nephrolithiasis four years prior, with intermittent left flank pain and hematuria. Chemical analysis showed the stones to be composed of uric acid. His medications included mesalamine, glyburide and rofecoxib. His physical examination was unremarkable. Laboratory values were significant for serum uric acid level of 7.0 mg/dl. Urinalysis revealed 0-3 white blood cells/hpf, 30-40 red blood cells/hpf , 3-5 epithelial cells/hpf and trace proteins. Renal ultrasound showed a right kidney of 12.4 cm and a left kidney of 12.2 cm with
机译:收集肾导管癌是一种众所周知的但相对罕见的肿瘤,其特征是细胞学分级高,增生性基质和临床效果差。但是,自1979年以来,已经有几项关于低级别肾癌的公认收集导管起源的报道。这些低度肿瘤为广泛的乳头状,微管乳头状或微管囊性,核级低(通常为Furhman 1级或2级)。即使仅通过部分肾切除术进行治疗,大多数患者也提供了良性的随访过程。此类肿瘤的先前报道已经在免疫组织化学和超微结构方面进行了可变地表征。我们报告了收集导管起源的低度肾癌的病例,这些病例发生在患有痛风和肾结石病史的47岁男性的右肾下极。在显微镜下,肿瘤显示出管状和微囊性形态,几乎完全由透明细胞组成,与传统的(透明细胞)肾细胞癌非常相似。 PAS染色呈阳性的肿瘤细胞,用Hale的胶体铁呈液滴状染色,阿尔辛蓝呈可变性,粘胭脂红呈阴性。它们与针对花生凝集素(PNA),欧洲油曲霉1凝集素(UEA-1),泛细胞角蛋白,CAM 5.2,细胞角蛋白7,上皮膜抗原(EMA)和波形蛋白的免疫组化抗体反应。电子显微镜显示微孔内衬的肾小管,桥粒和扁桃体丝,线粒体很少。该患者接受了部分肾切除术治疗,并且没有任何疾病迹象,随访期为10个月。前言肾脏的集合管癌是相对罕见的肿瘤,通常被认为是表达正常的肾脏集合管表型标记的高级别肿瘤,包括高分子量细胞角蛋白(HMWK,34 + E12),欧洲油曲霉1凝集素(UEA- 1),花生凝集素(PNA)和上皮膜抗原(EMA)1、2、3、4。这些肿瘤以牢固的一致性和灰白色的颜色大致位于肾髓质中。在显微镜下,它们通常是管状或管状乳头状核,具有较高的核级和明显的增生基质。临床结果差,诊断后2年内约有66%的患者死亡。4。1979年,Cromie等人描述了一种低度肾癌,其特征是肾小管和乳头状镜检,低核度,不存在增生并且明显起源于收集导管上皮。根治性肾切除术后,随访的临床过程是良性的。从那时起,已经报道了低度肾癌的其他报道,显然是收集导管或远端肾单位起源的,几乎所有的根治性切除术后都具有良性的随访临床过程。或部分肾切除术6,7,8,9,10。其中大多数已通过组织化学和免疫组织化学进行了研究,只有超微结构的5,7,8检查了10个。当前描述的病例的重要性在于其与常规(透明细胞)肾细胞癌惊人的组织学相似性,很容易将其与之混淆。病例报告一名47岁的白人男性在显微镜下血尿的评估中被发现在其右肾下极的2.0厘米实心肿块。他过去的病史对克罗恩病,II型糖尿病和痛风具有重要意义。四年前,他患有单发性肾结石,伴有间歇性左胁腹疼痛和血尿。化学分析表明,结石由尿酸组成。他的药物包括美沙拉敏,格列本脲和罗非昔布。他的身体检查不明显。血清尿酸水平为7.0 mg / dl时,实验室值很显着。尿液分析显示0-3个白细胞/ hpf,30-40个红细胞/ hpf,3-5个上皮细胞/ hpf和微量蛋白质。肾脏超声显示右肾为12.4厘米,左肾为12.2厘米,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号